Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Res Dev Disabil. 2012 Jul-Aug;33(4):1147-56. doi: 10.1016/j.ridd.2012.02.009. Epub 2012 Mar 7.
Individuals with disabilities are a growing population that confronts multiple disadvantages from social and environmental determinants of health. In particular, the 7-8 million people in the U.S. with an intellectual disability (ID) suffer disproportionately from substance use problems, largely because of a lack of empirical evidence to inform prevention and treatment efforts for them. Although available research could inform future research efforts, studies are scattered across disciplines with the last review synthesizing findings written more than five years ago. To consider more recent findings with earlier works, PubMed, PsychINFO, and Google Scholar were searched and produced 37 peer-reviewed texts across multiple disciplines, 15 from 2006 or later. While the prevalence of alcohol and illicit drug use in this population are low, the risk of having a substance-related problem among ID substance users is comparatively high. Gaps in the research and population subgroups that warrant special attention are identified, such as individuals with borderline and mild ID, individuals with co-occurring mental illness, and individuals who are incarcerated. Compared with substance abusers without ID, ID substance abusers are less likely to receive substance abuse treatment or remain in treatment. Research is needed to better gauge the magnitude of substance use problems, identify prevention strategies, and specify treatment components that meet the unique needs of individuals with ID.
残疾人是一个不断增长的群体,他们面临着多种来自社会和环境健康决定因素的不利因素。特别是,美国有 700 万至 800 万人患有智力残疾 (ID),他们不成比例地受到药物使用问题的困扰,这主要是因为缺乏经验证据来为他们的预防和治疗工作提供信息。尽管现有研究可以为未来的研究工作提供信息,但这些研究分散在各个学科中,最后一次综合研究结果的综述是在五年前撰写的。为了考虑最近的发现和早期的研究,对 PubMed、PsychINFO 和 Google Scholar 进行了检索,产生了来自多个学科的 37 篇同行评议文本,其中 15 篇发表于 2006 年或之后。虽然该人群中酒精和非法药物的使用普遍较低,但 ID 药物使用者出现与物质相关问题的风险相对较高。确定了研究和人口亚组中的差距,需要特别关注,例如边缘型和轻度 ID 个体、同时患有精神疾病的个体以及被监禁的个体。与没有 ID 的药物滥用者相比,ID 药物滥用者接受药物滥用治疗或继续治疗的可能性较小。需要研究来更好地衡量药物使用问题的严重程度,确定预防策略,并确定符合 ID 个体独特需求的治疗内容。